Filter
684
Text search:
Innovation
Featured
Recommendations
58
New Publications
146
Language
Document type
No document type
295
Studies & Reports
211
Guidelines
64
Strategic & Response Plan
54
Manuals
39
Fact sheets
9
Situation Updates
3
Resource Platforms
3
Training Material
2
Brochures
2
Infographics
1
Online Courses
1
Countries / Regions
Global
38
Kenya
28
India
20
South Africa
15
Rwanda
13
Western and Central Europe
12
Africa
12
Nepal
11
Senegal
10
Latin America and the Carribbean
10
Burkina Faso
9
Nigeria
9
Congo, Democratic Republic of
9
Syria
9
Ethiopia
8
Ghana
8
Uganda
8
Zambia
6
South–East Asia Region
6
Asia
6
Guinea
5
Sierra Leone
5
Philippines
5
Tanzania
5
Malawi
5
Brazil
5
East and Southern Africa
5
West and Central Africa
5
Cameroon
4
Germany
4
Thailand
4
Colombia
4
Liberia
3
Mali
3
Côte d’Ivoire / Ivory Coast
3
South Sudan
3
Jordan
3
Lebanon
3
China
3
Bangladesh
3
Ukraine
3
Myanmar / Burma
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Eastern Europe
3
Russia
3
Somalia
2
Iraq
2
Afghanistan
2
Chad
2
Cambodia
2
Indonesia
2
Mozambique
2
Namibia
2
Botswana
2
Western Pacific Region
2
Morocco
1
USA
1
Niger
1
Zimbabwe
1
Haiti
1
Pakistan
1
Gambia
1
Mauritania
1
Benin
1
Argentina
1
Peru
1
North Macedonia
1
Hungary
1
Libya
1
Angola
1
Madagascar
1
Mexico
1
Sri Lanka
1
Chile
1
Yemen
1
Venezuela
1
Palestine
1
Armenia
1
Mongolia
1
Laos
1
Canada
1
Timor Leste/ East Timor
1
Estonia
1
Moldova
1
Iran
1
Kyrgyzstan
1
Georgia
1
Turkmenistan
1
Jamaica
1
Japan
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
188
Public Health
50
Key Resources
42
Clinical Guidelines
36
Women & Child Health
25
Pharmacy & Technologies
13
Capacity Building
6
Toolboxes
COVID-19
60
HIV
57
Planetary Health
54
Mental Health
46
TB
38
Disability
34
AMR
34
Global Health Education
32
Health Financing Toolbox
20
NTDs
18
Conflict
17
Caregiver
16
Ebola & Marburg
14
Refugee
11
Rapid Response
9
Social Ethics
9
NCDs
9
Malaria
9
Pharmacy
7
Natural Hazards
6
Polio
4
2.0 Rapid Response
4
Cholera
2
Zika
2
Specific Hazards
1
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities
...
Le profil pharmaceutique du pays présente des données sur les conditions socioéconomiques existantes et celles de la santé, les ressources, les structures règlementaires, les processus et les résultats relatifs au secteur pharmaceutique au Burkina-Faso. Ce document a pour but de compiler toute
...
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive f
...
This new plan has been developed to build on successes made and lessons learnt from implementation of the two initial plans and to provide a short to medium term strategic anchor against which preparedness and response plans to the corona virus disease COVID-19 epidemic in the country should focus o
...
This document synthesizes key elements of the World Health Organization (WHO) normative guidance on health policy and system support for community health worker (CHW) programmes and their application for HIV programmes. Building on relevant elements of HIV guidelines, tools and evidence identified b
...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau
...
This thematic brief accompanies the Working for Health 2022–2030 Action Plan, serving as a rationale to the related actions of the Working for Health progression model (see Annex). The brief aims to inform Member States, non-state actors and other users of the Action Plan to guide action on inves
...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr
...
The present information document supplements the WHO audited financial statements for 2018. It contains information on WHO's voluntary contributions by fund and by contributor in the year 2018.
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa
...
The Fourth National Climate Assessment (NCA4) fulfills that mandate in two volumes. This report, Volume II, draws on the foundational science described in Volume I, the Climate Science Special Report (CSSR).2 Volume II focuses on the human welfare, societal, and environmental elements of climate cha
...
It is often observed that educated women have lower birth rates than do the less educated, inviting a causal interpretation. However, educated women also differ from those who have never attended school in a
variety of other ways: the two factors are multiply related. This article analyzes the rela
...
The first case of COVID-19 was reported in Mozambique on 22 March 2020. As of 26 May, Mozambique had 194 confirmed cases of COVID-19, of which 168 were locally transmitted. The country’s capital, Maputo, and the province of Cabo Delgado are currently the epicentres of the outbreak in Mozambique, w
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
